Treatment for Chronic Diarrhea
For adults with chronic diarrhea lasting more than 4 weeks, treatment should begin with lifestyle modifications (regular meals, exercise, adequate hydration, limiting caffeine/alcohol) and dietary changes (low-FODMAP diet), followed by first-line pharmacotherapy with loperamide (opiate agonist) or probiotics, which improve symptoms in 50-80% of patients 1.
Treatment Algorithm
Step 1: Identify and Treat Secondary Causes First
Before initiating symptomatic treatment, you must rule out and address specific etiologies 2:
- Drug-induced diarrhea: Review medications and discontinue offending agents
- Bile acid diarrhea: Treat with bile acid sequestrants (cholestyramine) 3
- Celiac disease: Gluten-free diet
- Microscopic colitis: Budesonide or other anti-inflammatory therapy
- Small intestinal bacterial overgrowth: Antibiotics (rifaximin)
- Inflammatory bowel disease: Disease-specific therapy
- Endocrine causes (thyrotoxicosis, diabetes): Treat underlying condition 3
Step 2: Lifestyle and Dietary Modifications (First-Line for Functional Diarrhea)
Implement these evidence-based changes 1:
- Regularly scheduled meals with consistent timing
- Exercise regularly
- Fluid intake: At least 8 cups of non-caffeinated fluids daily
- Limit caffeine to ≤3 cups daily
- Avoid alcohol and carbonated beverages
- Low-FODMAP diet: Reduce fermentable oligosaccharides (legumes, wheat, onions, garlic), disaccharides (lactose), monosaccharides (fructose), and polyols (sorbitol, mannitol) 1, 4
Step 3: First-Line Pharmacotherapy
When lifestyle modifications are insufficient, initiate medication 2, 1:
Primary options:
- Loperamide (opiate agonist): Most established first-line agent for symptomatic control 1, 4
- Probiotics: For gut microbiome regulation 2
Alternative first-line agents:
- Anticholinergics (hyoscyamine, dicyclomine): Reduce intestinal motility 1
- 5-HT3 receptor antagonists (ondansetron): Particularly effective for IBS-D 1, 4
Step 4: Second-Line and Refractory Treatment
For patients not responding to initial therapy 4, 2:
- Rifaximin: Non-absorbable antibiotic for IBS-D
- Low-dose tricyclic antidepressants: For intractable IBS-D
- Eluxadolin: Modulates opioid receptors in enteric nervous system for IBS-D with abdominal pain
- Cholestyramine: If bile acid diarrhea suspected but not confirmed
- Bulking agents: Limited evidence but may help some patients
- Kampo medicine: Insufficient evidence but used in some populations 2
Critical Diagnostic Considerations Before Treatment
The British Society of Gastroenterology guidelines emphasize that certain patients require investigation before empiric treatment 3:
Alarm features requiring urgent evaluation:
- Unexplained weight loss
- Persistent blood in stool
- Age ≥45 years with new-onset symptoms
- Nocturnal diarrhea
- Steatorrhea
- Iron deficiency anemia
- Family history of colorectal cancer or inflammatory bowel disease
Essential baseline testing 1, 5:
- Tissue transglutaminase IgA + total IgA (celiac disease)
- Fecal calprotectin (inflammatory bowel disease)
- Complete blood count, C-reactive protein
- Basic metabolic panel
Colonoscopy with random biopsies is recommended for alarm features to evaluate for colorectal cancer and microscopic colitis, which affects 13% of chronic diarrhea patients 1.
Common Pitfalls to Avoid
Don't assume infectious etiology: Over 90% of chronic diarrhea cases are non-infectious 1
Don't overlook microscopic colitis: This requires random biopsies during colonoscopy as the mucosa appears normal endoscopically 1
Don't forget bile acid diarrhea: This typically occurs after meals, responds to fasting, and is treated with bile acid sequestrants—particularly common after terminal ileum resection 3
Don't miss medication review: Many drugs cause diarrhea as a side effect 2, 6
Don't ignore dietary triggers: Excessive caffeine, lactose in lactase-deficient patients, sorbitol, and fructose are common culprits 3
Expected Treatment Response
The most recent high-quality evidence indicates that lifestyle modifications, dietary changes, and first-line medications (loperamide, anticholinergics, 5-HT3 antagonists) typically improve diarrhea in 50-80% of patients 1. This success rate applies primarily to functional diarrhea and IBS-D, which together represent the most common causes of chronic non-infectious diarrhea.
Special Populations
Post-surgical patients: Those with extensive ileal/right colon resections develop diarrhea from reduced absorptive surface, while shorter terminal ileum resections cause bile acid diarrhea responding to sequestrants 3.
Alcohol abuse: Direct toxic effects on intestinal epithelium, rapid transit, and decreased pancreatic function contribute to diarrhea 3.